A point mutation in the human transporter associated with antigen processing (TAP2) alters the peptide transport specificity - PubMed (original) (raw)

A point mutation in the human transporter associated with antigen processing (TAP2) alters the peptide transport specificity

E A Armandola et al. Eur J Immunol. 1996 Aug.

Abstract

The heterodimeric transporter associated with antigen processing (TAP1/TAP2) translocates peptides from the cytosol into the endoplasmic reticulum where loading of major histocompatibility complex class I molecules takes place. TAP transporters from different species are known to exhibit distinct transport specificities with regard to the C-terminal amino acid (aa) of peptides. Thus, human TAP (hTAP), and rat TAP (rTAP) containing the rTAP2a allele are rather promiscuous, whereas mouse TAP (mTAP), and rTAP containing the rTAP2a allele are restrictive and select against peptides with C-terminal small polar/hydrophobic or positively charged aa. The structural basis for this selectivity is not clear. To assess the relative contribution of the TAP1 and TAP2 subunits to transport specificity, we have constructed and analyzed interspecies TAP hybrids and point mutants of hTAP2 expressed in Sf9 insect cells and in TAP-deficient T2 cells. Transport assays with 20 C-terminal variants of the peptide RYWANATRSX showed that: first, transport specificity with regard to C-terminal aa is mainly influenced by TAP2, but TAP1 can also contribute. Second, the selective transport of peptides with C-terminal positively charged aa is critically controlled by the amino-terminal region (1-361) on the TAP2 chain, while transport of peptides with C-terminal small polar/hydrophobic aa is determined by residues located within as well as outside the region 1-361. Third, a single point mutation in hTAP2 (374A-->D) resulted in a drastic alteration of the transport pattern. These results indicate that both TAP1 and TAP2 contribute to efficient peptide transport and that single point mutations in hTAP2 are able to alter the peptide transport specificity. This opens the possibility that naturally occurring mutations in one of the hTAP subunits may alter epitope selection in vivo.

PubMed Disclaimer

Cited by

Structure of the transporter associated with antigen processing trapped by herpes simplex virus.
Oldham ML, Grigorieff N, Chen J. Oldham ML, et al. Elife. 2016 Dec 9;5:e21829. doi: 10.7554/eLife.21829. Elife. 2016. PMID: 27935481 Free PMC article.
Exploiting the exploiter: a viral inhibitor stabilizes TAP for cryo-EM.
Luteijn RD, Wiertz EJ. Luteijn RD, et al. Nat Struct Mol Biol. 2016 Feb;23(2):95-7. doi: 10.1038/nsmb.3168. Nat Struct Mol Biol. 2016. PMID: 26840895 No abstract available.
A highly conserved sequence of the viral TAP inhibitor ICP47 is required for freezing of the peptide transport cycle.
Matschulla T, Berry R, Gerke C, Döring M, Busch J, Paijo J, Kalinke U, Momburg F, Hengel H, Halenius A. Matschulla T, et al. Sci Rep. 2017 Jun 7;7(1):2933. doi: 10.1038/s41598-017-02994-5. Sci Rep. 2017. PMID: 28592828 Free PMC article.
The human transporter associated with antigen processing: molecular models to describe peptide binding competent states.
Corradi V, Singh G, Tieleman DP. Corradi V, et al. J Biol Chem. 2012 Aug 10;287(33):28099-111. doi: 10.1074/jbc.M112.381251. Epub 2012 Jun 14. J Biol Chem. 2012. PMID: 22700967 Free PMC article.
Use of Functional Polymorphisms To Elucidate the Peptide Binding Site of TAP Complexes.
Geng J, Pogozheva ID, Mosberg HI, Raghavan M. Geng J, et al. J Immunol. 2015 Oct 1;195(7):3436-48. doi: 10.4049/jimmunol.1500985. Epub 2015 Aug 31. J Immunol. 2015. PMID: 26324772 Free PMC article.

A point mutation in the human transporter associated with antigen processing (TAP2) alters the peptide transport specificity - PubMed (original) (raw)